Medical News

RSS

EBRI findings show employers and workers expect increase in health benefit costs

New findings by the Employee Benefit Research Institute (EBRI) show that both employers and workers say they are not very knowledgeable about health reform, but that employers say they are likely to pass along any health benefit cost increases to workers -- and, mostly, workers are expecting such cost increases.

25 Jan 2011

Promising results from TheraTears Nutrition pilot trial in dry eye patients

Advanced Vision Research, Inc. today announced the publication in the journal Cornea of promising results from a pilot trial of dry eye patients taking TheraTears® Nutrition. The study demonstrated a reduction in dry eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears® Nutrition, an optimized blend of medical grade essential omega-3 oils, including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and flaxseed oil.

25 Jan 2011

New study finds disparities in chlamydia screening

A new study from the Indiana University School of Medicine and the Regenstrief Institute has found that Black and especially Hispanic young women are screened for chlamydia at a significantly higher rate than young white women. This discrepancy in screening rates may contribute to nationwide reporting of higher rates of this sexually transmitted disease among minority young women.

25 Jan 2011

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

After 27 years of service, decorated U.S. Army Brigadier General Becky Halstead (Retired), the first female West Point graduate in U.S. history to command at the strategic level in Iraq and Afghanistan, decided to retire after being diagnosed with fibromyalgia - a medically unexplained syndrome affecting the muscles and connective tissues.

25 Jan 2011

New study finds unrealistic optimism prevalent among participants in early-phase cancer trials

Can optimism be ethically problematic? Yes, according to a new study, which found unrealistic optimism prevalent among participants in early-phase cancer trials and suggested that it may compromise informed consent.

25 Jan 2011

East Liverpool City Hospital, Foundation Radiology Group enter imaging services agreement

Foundation Radiology Group, the premier provider of diagnostic imaging professional services for community hospitals, is pleased to announce its exclusive imaging services agreement with East Liverpool City Hospital located in East Liverpool, Ohio.

25 Jan 2011

Cardiac Science receives U.S. Army's AWR certification for automated defibrillator

Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, has been awarded Airworthiness Release from the U.S. Army's Research, Development, and Engineering Command for the Powerheart AED G3 Pro automated defibrillator.

25 Jan 2011

p38-targeted compounds hold promise for Alzheimer's disease treatment

Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, has been awarded a $750,000 grant to further her research into a possible treatment for Alzheimer's disease. The grant is from the Edward N. And Della L. Thome Memorial Foundation, and was one of only eight Awards in Alzheimer's Disease Drug Discovery Research to be given in the U.S. in 2010.

25 Jan 2011

Human model of rare genetic disease reveals new clues to aging process

Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.

25 Jan 2011

Vaccination campaigns to stop yellow fever spread get underway in E. Africa

Individuals traveling across East Africa on Friday were ordered to begin receiving mandatory yellow fever vaccines in an effort "to contain an outbreak of the disease in Uganda," which has sickened an estimated 190 people, resulting in 48 deaths as of Dec. 30, 2010, the Citizen reports (Ubwani, 1/22).

25 Jan 2011

Researchers design engineered organ study the use of nanoparticles in breast cancer detection

Purdue University researchers have reproduced portions of the female breast in a tiny slide-sized model dubbed "breast on-a-chip" that will be used to test nanomedical approaches for the detection and treatment of breast cancer.

25 Jan 2011

Simple means of improving binding affinity of synbodies

Antibodies are watchdogs of human health, continuously prowling the body and registering minute changes associated with infection or disease with astonishing acuity. They also serve as biochemical memory banks, faithfully recording information about pathogens they encounter and efficiently storing this data for later use.

25 Jan 2011

Research finds faster developmental rate incurs lethal physiological costs for individuals

Fast development is often perceived as an advantage, as it enables better harmony with one's environment and readiness to cope with the challenges that it poses. However, research conducted at the University of Haifa, Israel, and University of California, Santa Cruz, and published in the scientific journal PLoS ONE, found that the acceleration of developmental rate incurs potentially lethal physiological costs for the developing individual.

25 Jan 2011

ASA concerned over non-availability of sodium thiopental

The American Society of Anesthesiologists (ASA) and its members are extremely troubled to learn that the anesthetic drug, sodium thiopental (Pentothal®), will no longer be available to patients in the U.S. or any other country due to the unfortunate circumstances in Italy that led the sole manufacturer, Hospira, to cease production of the drug.

25 Jan 2011

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

A new company has been launched to commercialise an award-winning technology, developed at the University of Strathclyde in Glasgow, for tackling bacterial infection and contamination, including superbugs such as MRSA.

25 Jan 2011

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

25 Jan 2011

Researchers find White-Hispanic disparities in receiving immunization against flu, pneumonia

Seniors of Hispanic descent are far less likely to become immunized against the flu or pneumonia compared to similar White seniors, according to a new RAND Corporation study.

25 Jan 2011

UAE Oasis Hospital to implement Quantros suite of patient safety and compliance solutions

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has partnered with Oasis Hospital, the first private hospital in the Emirate of Abu Dhabi, United Arab Emirates (UAE) to receive Joint Commission International accreditation, to implement the Quantros suite of patient safety and compliance solutions.

25 Jan 2011

TU Delft receives EU grant to diagnose and monitor Crohn's disease using MRI scans

Colonoscopy is the standard intestinal examination for diagnosing and monitoring Crohn's disease. It is a stressful procedure in which a flexible tube fitted with a camera is passed into the large intestine. MRI scans are therefore often used as an alternative to monitor the course of the disease and how it is responding to treatment.

25 Jan 2011

FDA approves Matrix's generic Protonix DR Tablets ANDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-release (DR) Tablets USP, 20 mg (base) and 40 mg (base), the generic version of Wyeth's Protonix® DR Tablets, a treatment for the irritation of the esophagus caused by gastroesophageal reflux disease (GERD).

25 Jan 2011

Medical News

EBRI findings show employers and workers expect increase in health benefit costs

Promising results from TheraTears Nutrition pilot trial in dry eye patients

New study finds disparities in chlamydia screening

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

New study finds unrealistic optimism prevalent among participants in early-phase cancer trials

East Liverpool City Hospital, Foundation Radiology Group enter imaging services agreement

Cardiac Science receives U.S. Army's AWR certification for automated defibrillator

p38-targeted compounds hold promise for Alzheimer's disease treatment

Human model of rare genetic disease reveals new clues to aging process

Vaccination campaigns to stop yellow fever spread get underway in E. Africa

Researchers design engineered organ study the use of nanoparticles in breast cancer detection

Simple means of improving binding affinity of synbodies

Research finds faster developmental rate incurs lethal physiological costs for individuals

ASA concerned over non-availability of sodium thiopental

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

SNM commends FDA Advisory Committee recommendation for florbetapir approval

Researchers find White-Hispanic disparities in receiving immunization against flu, pneumonia

UAE Oasis Hospital to implement Quantros suite of patient safety and compliance solutions

TU Delft receives EU grant to diagnose and monitor Crohn's disease using MRI scans

FDA approves Matrix's generic Protonix DR Tablets ANDA

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News